Obesity and Breast Cancer: Interaction or Interference with the Response to Therapy?

Silvia RiondinoVincenzo FormicaElena ValenziCristina MorelliValeria FlaminioIlaria PortarenaFrancesco Torino Mario Roselli

Published in: Current oncology (Toronto, Ont.) (2023)

in radically resected hormone-sensitive BC patients undergoing neoadjuvant or adjuvant chemotherapy and treated with AI, obesity represents a risk factor for recurrence, with a significantly reduced 2-year DFS.

Keyphrases

insulin resistance
patients undergoing
metabolic syndrome
weight loss
high fat diet induced
lymph node
type diabetes
weight gain
rectal cancer
artificial intelligence
adipose tissue
skeletal muscle
stem cells
radiation therapy
free survival
mesenchymal stem cells
bone marrow
newly diagnosed